AMLXAmylyx Pharmaceuticals, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $15.82 (+0.00% today)

Market Cap: $1.24B

P/E (TTM): -9.80

Analyst Upside: 48.5%

Relative Strength (RS%): 16

-9.5% from 52-week high

Back to Scanner

AMLX

NASDAQRS 16Score 39

Amylyx Pharmaceuticals, Inc.

HealthcareBiotechnology$1.24B2 setups passing
$15.82
0.0% ($0.00)
-9.5% from 52W High
P/E (TTM)
-9.80
Fwd P/E
PEG
Analyst Upside
+48.5%
EPS Growth
Gross Margin
0.0%
ROE
-57.5%
D/E
0.02
Div Yield
0.0%
Avg Volume
2.5M

Price Chart

Key Levels

SMA 200
$12.06
SMA 50
$14.34
Price
$15.82
52W High
$17.48
Target
$23.50

Setup Radar

2/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst